7-Chloro-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-ol, 98%, 100g

L-Citrulline DL-malate (1:1), 95.0%, 100g

Solution de formaldéhyde 30 %, faible teneur en méthanol, 2,5 l

1-Chloro-3-(2,2,2-trifluoroethyl)benzene, 95.0%, 25g

3-Cyclobutene-1,2-dione, 3-[[(1S,2S)-2-aminocyclohexyl]amino]-4-[[3,5-bis(trifluoromethyl)phenyl]amino]-, 97%, 100mg

(4-((PHENOXYCARBONYL)AMINO)PHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 250mg

3'-bromo-3-(4-bromophenyl)propiophenone, 97.0%, 1g

5-Bromo-1,2-difluoro-3-nitrobenzene, 95.0%, 25g

methyl 4-bromo-2-(oxan-4-yl)-1H-imidazole-5-carboxylate, 98%, 100mg

7-Oxospiro[3.5]nonane-2-carboxylic acid, 97%, 500mg

5-(2,5-dimethylphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

1,3,4-oxadiazol-2-ol, 95.0%, 500mg

Colonne capillaire GC ROTI®Cap-5 HT, 30 m, 0,25 mm, 0,10 µm, 1 pièce(s)